Here’s a number that should keep you awake at night: 700,000.

That’s how many children die from pneumonia every year. Not in some distant historical era, but right now. In 2025. While we carry supercomputers in our pockets and send robots to Mars.

For context, that’s more deaths than malaria, measles, and HIV/AIDS combined. And here’s the part that makes it unconscionable: we know how to stop it.

Every November 12, World Pneumonia Day asks us to confront an uncomfortable question: Why are we letting children die from a disease we solved decades ago?

The disease you’ve never heard of

Let me tell you what pneumonia actually is, because most people in wealthy countries have the luxury of not knowing.

It’s an infection that fills your lungs with fluid. Your air sacs, the tiny alveoli that transfer oxygen to your blood, become inflamed, swollen, and packed with pus. Breathing becomes work. Then it becomes agony. Then, if you’re a child in a place without access to antibiotics or oxygen, it becomes impossible.

The cause can be bacterial, viral, or fungal. The symptoms are brutal: fever, chills, a cough that produces blood-flecked phlegm, chest pain with every breath. For an adult with access to healthcare, it’s a week of misery followed by recovery. For a child in rural sub-Saharan Africa or South Asia, it’s often a death sentence.

And here’s what makes pneumonia different from the diseases that capture headlines: it’s boring. It doesn’t have the dramatic narrative of Ebola or the political charge of HIV. It just kills quietly, consistently, overwhelmingly in places we don’t see.

The geography of survival

There’s a pattern here, and it’s one we see again and again in global health: your zip code determines your lifespan.

If a child in Norway gets pneumonia, they receive antibiotics within hours. Pneumococcal vaccines are standard. Healthcare is free and accessible. The child recovers.

If a child in Chad gets pneumonia, there’s a decent chance there’s no clinic within walking distance. No vaccines because the supply chain is broken. No antibiotics because they cost more than a family’s monthly income. No oxygen because the hospital has one tank and twenty patients.

Same disease. Different outcomes. Not because of biology, but because of economics.

This is what inequality actually looks like. Not abstract wealth gaps or policy debates, but a five-year-old struggling to breathe while the medication that could save her sits in a warehouse 3,000 miles away.

The innovation that didn’t spread

The 2025 theme for World Pneumonia Day is “Innovate to Eliminate.” And there’s something darkly ironic about that phrase, because we’ve already innovated. The problem isn’t invention, it’s distribution.

We have pneumococcal vaccines that prevent the most common bacterial cause of pneumonia. They’ve been around since 2000. In wealthy countries, nearly every child gets them. In low-income countries, coverage is spotty at best.

We have antibiotics that cure bacterial pneumonia. They cost pennies to manufacture. But when your family survives on two dollars a day, pennies might as well be millions.

We have oxygen concentrators that can keep a child alive while their body fights the infection. The technology is simple, robust, and effective. But it requires electricity, which half of sub-Saharan Africa lacks reliable access to.

This is the frustrating reality of global health: the solutions exist. They’re sitting there, proven, waiting. What we lack isn’t innovation, it’s will.

The pandemic we ignored

COVID-19 taught us something important about respiratory infections: they expose every weakness in a healthcare system.

In 2020, the world suddenly cared about pneumonia. Because that’s what COVID-19 caused, viral pneumonia that filled lungs with fluid and sent patients scrambling for ventilators. Wealthy countries hoarded oxygen. Hospitals overflowed. We finally understood what it meant to struggle for breath.

But here’s what we forgot: children in low-income countries have been experiencing this for decades. Not from a novel coronavirus, but from common bacteria and viruses that we vaccinate against in wealthy nations.

The pandemic revealed our capacity for rapid response when we feel threatened. It also revealed our indifference when the threat is somewhere else.

The math of preventable death

Let’s do some arithmetic that should make you angry.

Pneumonia kills 700,000 children per year. The pneumococcal vaccine costs about $3.50 per dose in developing countries. Two doses provide substantial protection.

So: 700,000 children × $7 = $4.9 million.

That’s roughly what the United States spends on its military every 45 minutes.

I’m not saying it’s that simple; distribution, infrastructure, and healthcare systems matter enormously. But the point stands: this isn’t a resource problem. It’s a priority problem.

We could eliminate childhood pneumonia deaths. We choose not to because the children who are dying don’t live in places that matter to people making decisions.

What inequality looks like up close

The WHO and UNICEF launched something called GAPPD, the Integrated Global Action Plan for Pneumonia and Diarrhea. The goal was to reduce child mortality from these preventable diseases.

You know what’s remarkable about that acronym? That we needed to create a special program to address diseases we solved half a century ago.

Pneumonia accounts for 15% of all child deaths worldwide. Fifteen percent. Despite being both preventable and treatable with interventions that cost almost nothing.

This isn’t a medical mystery. It’s a distribution failure of such magnitude that it stops being about health and starts being about values.

The children we don’t count

There’s a reason pneumonia is called “the forgotten killer.” It doesn’t generate compelling news coverage. There are no ribbon campaigns. No celebrity spokespeople. Just 700,000 quiet deaths every year, most of them invisible to people with the power to change things.

These children die from what their parents call “fever” or “bad cough.” They die in homes, not hospitals. They die without being counted in statistics, without birth certificates or death certificates, without leaving any record that they existed at all.

When we talk about “global health equity,” this is what we mean. Not everyone getting the same care, that might be unrealistic. But everyone getting the minimum care necessary to survive preventable diseases.

Right now, we’re failing that test catastrophically.

The question we’re afraid to ask

World Pneumonia Day forces us to confront something uncomfortable: How much is a child’s life worth?

Because that’s really what this comes down to. We have the technology, the medicine, the knowledge. What we lack is the collective decision that every child, regardless of where they’re born, deserves access to them.

In wealthy countries, we spend hundreds of thousands of dollars to save a single life. In low-income countries, children die because we won’t spend seven dollars on a vaccine.

This isn’t about capability. It’s about what we value and who we see as mattering.

What November 12 actually means

World Pneumonia Day isn’t about raising awareness in the traditional sense. Most people have heard of pneumonia. They know it exists.

What it’s really about is forcing us to see the children we’ve chosen not to see. The ones dying from a disease that a course of antibiotics could cure. The ones who would survive if they’d been born 5,000 miles west or north.

This November 12, the question isn’t “How can we innovate?” It’s “Why haven’t we distributed the innovations we already have?”

The answer, uncomfortable as it is, tells us everything we need to know about who we are and who we’ve decided matters.

The forgotten killer keeps killing because we keep forgetting. Maybe it’s time to remember.